CareCloud Reports Q3 Earnings Per Share of 10 Cents Compared to 21 Cents Last Year
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 06 2025
0mins
Q3 Revenue Growth: CareCloud reported Q3 revenue of $31.1 million, an increase from $28.5 million in the previous year.
Positive Outlook: The company raised its full-year 2025 revenue guidance, indicating strong performance and growth.
Impact of Acquisitions: The growth is attributed to the successful acquisitions of Medsphere and Map App, which have expanded CareCloud's presence in the hospital market.
Focus on Care Settings: The acquisitions have enhanced CareCloud's capabilities in both ambulatory and inpatient care settings.
Analyst Views on CCLD
Wall Street analysts forecast CCLD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CCLD is 6.00 USD with a low forecast of 6.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 2.870
Low
6.00
Averages
6.00
High
6.00
Current: 2.870
Low
6.00
Averages
6.00
High
6.00
About CCLD
CareCloud, Inc. is a provider of technology-enabled services and generative artificial intelligence (AI) solutions that redefine the healthcare revenue cycle management process. It provides technology-enabled revenue cycle management and a full suite of proprietary cloud-based solutions to healthcare providers, from small practices to enterprise medical groups, hospitals, and health systems throughout the United States. Its Healthcare IT segment includes technology-assisted revenue cycle management, software-as-a-service solutions and professional and other services. Its Medical Practice Management segment includes the management of three medical practices. Its technology-enabled business solutions include Technology-enabled revenue cycle management, Cloud-based software, Digital health, and Healthcare IT professional services & staffing. Its revenue cycle management services, including end-to-end medical billing, eligibility, analytics, and related services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
